1/5NRX Pharmaceuticals, Inc. (NRXP): Filing-delay notice, quarterly report filed within extension (NT 10-Q)

Market data

Price before filing: $2.53 (2025-08-13 close, split/dividend-adjusted)
Market cap at flag: $59.4M (2025-08-14) · Latest: $97.9M (2026-10-16)

What happened next

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Verified excerpt

"(the " Company ") is unable file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the " Form 10-Q ") by the prescribed due date without unreasonable effort or expense because the Company requires additional time to compile certain information into the Form 10-Q necessary for a complete presentation. The Company expects to file the Form 10-Q on or before the 5th calendar day following the..."

Quoted from the filing. Source

What this means

The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.

Status: filed within extension (report filed 2025-08-18) · the SEC treats a report filed within the extension as timely

Why this score: report filed within the extension on 2025-08-18